Chugai's Hemlibra Receives Approval for Severe Hemophilia A Without Factor VIII Inhibitors from the European Commission

Esperion Therapeutics reveals positive results for bempedoic acid

The European Commission approves Roche's haemophilia drug Hemlibra

Karyopharm reports US FDA's extension of Selinexor NDA review period to 6 July 2019

BD wins the US FDA's premarket approval for Venovo venous stent for iliofemoral venous occlusive disease

Pharmaceutics International announces US FDA's EIR

Q-linea's first product expected to reach its main market earlier than planned

Abbott wins US FDA approval for new, expanded indication for MitraClip device to address the secondary form of MR

BIOTRONIK to introduce Acticor and Rivacor high-voltage cardiac rhythm management (CRM) devices in the US in April 2019

The FDA authorises marketing of new ClearMate device to help treat carbon monoxide poisoning

FDA Grants Purdue Pharma's Nalmefene HCl Injection Fast Track Designation for the Emergency Treatment of Known or Suspected Opioid Overdose

Celgene Provides Update on Abraxane Combination Therapy in the Treatment of Metastatic Triple-Negative Breast Cancer and Pancreatic Cancer

Aerie Pharmaceuticals Receives US FDA Approval of Rocklatan 0.02%/0.005% for the Reduction of Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension

The US Food and Drug Administration approves Regeneron and Sanofi's Dupixent

Flow Pharma, OncoImmunity AS partner for the Development of FlowVax Personalised Cancer Vaccines